VIRIDIAN THERAPEUTICS INC

2026. g. 7. aug. 20:05 UTC

Viridian Therapeutics shares rise after Truist Securities raised its price target to $39. The ARK Genomic Revolution ETF's gains may also influence the stock.

2026. g. 6. aug. 21:02 UTC

Viridian Therapeutics Inc is trading higher in after-market hours, extending five consecutive sessions of gains amid broader market resilience and positive economic data.

2026. g. 5. aug. 23:02 UTC

Viridian Therapeutics Inc shares declined in after-market trading, sharply lower since Wednesday's close, despite finishing higher in the previous three sessions.

2026. g. 4. aug. 21:02 UTC

Viridian Therapeutics shares are lower in after-hours trading, declining from earlier session highs despite being above the 20-day moving average.

2026. g. 3. aug. 23:01 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, reaching their lowest point despite a prior period of stability. No specific news was identified.

2026. g. 31. jūl. 20:02 UTC

Viridian Therapeutics Inc's shares are lower today, breaking a trend of higher closes. Broader market factors, including rising Treasury yields, may be influencing this shift.

2026. g. 30. jūl. 23:01 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, following earlier stability. Broader market uncertainty over the Federal Reserve's rate decision persists.

2026. g. 29. jūl. 23:56 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline. Broader market uncertainty persists.

2026. g. 28. jūl. 21:02 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, reversing an initial uptick amid cautious broader market sentiment and declines in technology shares.

2026. g. 27. jūl. 19:26 UTC

Viridian Therapeutics Inc is trading higher, maintaining strength since Friday's close and reflecting positive momentum near the upper end of its one-month trading range.

2026. g. 24. jūl. 17:36 UTC

Viridian Therapeutics shares are higher since Thursday's close, recovering from earlier lows. Broader market sentiment improved amid declining crude oil prices.

2026. g. 22. jūl. 19:26 UTC

Viridian Therapeutics Inc is trading higher during Wednesday's session, recovering from earlier lows despite the broader market's mixed performance.

2026. g. 21. jūl. 19:51 UTC

Viridian Therapeutics Inc shares are trading higher, reflecting strong intraday performance. The move aligns with positive sentiment in the biotechnology sector.

2026. g. 20. jūl. 19:01 UTC

Viridian Therapeutics Inc is advancing in Monday's session, despite earlier pullback. No specific company news was identified to explain the price movement.